Burden of Cancer and Utilization of Local Surgical Treatment Services in Rural Hospitals of Ethiopia: A Retrospective Assessment from 2014 to 2019.
Ethiopia
cancer
rural hospitals
surgical services
treatment pattern
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
03 11 2022
03 11 2022
Historique:
received:
14
12
2021
accepted:
18
05
2022
pubmed:
7
7
2022
medline:
8
11
2022
entrez:
6
7
2022
Statut:
ppublish
Résumé
Global cancer estimations for Ethiopia announced 77 352 new cases in 2020 based on the only population-based registry in Addis Ababa. This study characterizes cancer patients in rural Ethiopia at 8 primary and secondary hospitals between 2014 and 2019. All clinically or pathologically confirmed cancer cases that were diagnosed between 1 May 2014 and 29 April 2019 were included. A structured data extraction tool was used to retrospectively review patients' charts and descriptive analysis was done. A total of 1298 cancer cases were identified, of which three-fourths were females with a median age of 42 years. Breast (38%) and cervical (29%) cancers were the most common among females, while prostate (19%) and oesophageal cancers (16%) were the most common among males. Only 39% of tumors were pathologically confirmed. Nearly two-thirds of the cases were diagnosed at an advanced stage. Surgery was the only accessible treatment option for more than half of the cancer patients, and systemic treatment (except endocrine) was rarely available. One in 5 patients did not receive the recommended surgical procedure, half due to patient refusal or lack of the patient returning to the hospital. The pattern of cancer diagnoses in rural hospitals shows an exceptionally high burden in women in their middle-ages due to breast and cervical cancers. Advanced stage presentation, lack of pathology services, and unavailability of most systemic treatment options were common. The surgery was offered to nearly 60% of the patients, showing the significant efforts of health workers to reduce sufferings.
Sections du résumé
BACKGROUND
Global cancer estimations for Ethiopia announced 77 352 new cases in 2020 based on the only population-based registry in Addis Ababa. This study characterizes cancer patients in rural Ethiopia at 8 primary and secondary hospitals between 2014 and 2019.
PATIENTS AND METHODS
All clinically or pathologically confirmed cancer cases that were diagnosed between 1 May 2014 and 29 April 2019 were included. A structured data extraction tool was used to retrospectively review patients' charts and descriptive analysis was done.
RESULTS
A total of 1298 cancer cases were identified, of which three-fourths were females with a median age of 42 years. Breast (38%) and cervical (29%) cancers were the most common among females, while prostate (19%) and oesophageal cancers (16%) were the most common among males. Only 39% of tumors were pathologically confirmed. Nearly two-thirds of the cases were diagnosed at an advanced stage. Surgery was the only accessible treatment option for more than half of the cancer patients, and systemic treatment (except endocrine) was rarely available. One in 5 patients did not receive the recommended surgical procedure, half due to patient refusal or lack of the patient returning to the hospital.
CONCLUSION
The pattern of cancer diagnoses in rural hospitals shows an exceptionally high burden in women in their middle-ages due to breast and cervical cancers. Advanced stage presentation, lack of pathology services, and unavailability of most systemic treatment options were common. The surgery was offered to nearly 60% of the patients, showing the significant efforts of health workers to reduce sufferings.
Identifiants
pubmed: 35791963
pii: 6632453
doi: 10.1093/oncolo/oyac127
pmc: PMC9632304
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e889-e898Informations de copyright
© The Author(s) 2022. Published by Oxford University Press.
Références
J Multidiscip Healthc. 2021 Mar 19;14:681-694
pubmed: 33776446
JCO Glob Oncol. 2020 Feb;6:277-284
pubmed: 32109158
J Glob Oncol. 2018 Sep;4:1-11
pubmed: 30241262
Lancet Glob Health. 2016 Dec;4(12):e923-e935
pubmed: 27855871
PLoS One. 2019 Sep 19;14(9):e0219519
pubmed: 31536505
PLoS One. 2019 Aug 1;14(8):e0220769
pubmed: 31369640
Breast Cancer Res Treat. 2018 Jul;170(1):111-118
pubmed: 29479644
Infect Agent Cancer. 2017 Nov 29;12:61
pubmed: 29213299
Front Oncol. 2021 Feb 15;10:594342
pubmed: 33659206
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancer Manag Res. 2021 Feb 26;13:2071-2082
pubmed: 33664594
BMC Public Health. 2018 Aug 29;18(1):1072
pubmed: 30157813
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Lancet Oncol. 2015 Sep;16(11):1193-224
pubmed: 26427363
BMC Womens Health. 2019 Jan 7;19(1):4
pubmed: 30616640
Cancer Epidemiol. 2018 Apr;53:93-98
pubmed: 29414637
BMC Cancer. 2015 Jun 02;15:449
pubmed: 26031666
BMC Cancer. 2018 Mar 16;18(1):298
pubmed: 29548313
Lancet Oncol. 2015 Sep;16(11):1190-1
pubmed: 26427361
Clin Lab Med. 2018 Mar;38(1):161-173
pubmed: 29412880
Lancet Oncol. 2015 Sep;16(11):1188-9
pubmed: 26427359
PLoS One. 2020 Dec 1;15(12):e0242807
pubmed: 33259514
Gynecol Oncol Rep. 2017 Sep 01;22:16-20
pubmed: 28948205
BMJ Open. 2019 Nov 11;9(11):e032228
pubmed: 31719089
J Glob Oncol. 2018 Jul;4:1-12
pubmed: 30096010
Ethiop J Health Sci. 2017 May;27(3):255-262
pubmed: 29217924
Cancer Manag Res. 2021 Mar 23;13:2755-2762
pubmed: 33790649
JAMA Oncol. 2021 Feb 01;7(2):285-289
pubmed: 33355599
Clin Breast Cancer. 2021 Feb;21(1):e112-e119
pubmed: 33536135